Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWRVH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,157
Award facts
- Contract value 100% obligated
- $16,156.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,156.86 on June 3, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support agreement running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025.
This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and military healthcare systems. Dupixent is a biologic immunosuppressant medication used to treat conditions including moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma. AmerisourceBergen's role as a primary pharmaceutical distributor under the DLA Troop Support Medical IDC enables efficient fulfillment of specialized and brand-name medication requirements across the military healthcare enterprise. The expedited completion timeline and modest order value are consistent with routine replenishment orders under the broader prime vendor contract arrangement.
Quick answers
Who was awarded contract SPE2DB25FWRVH?
SPE2DB25FWRVH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FWRVH worth?
The government has obligated $16,157 on SPE2DB25FWRVH.
Is contract SPE2DB25FWRVH an order under another contract?
Yes. SPE2DB25FWRVH is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWRVH competed?
The extent of competition for SPE2DB25FWRVH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award